Skip to main content

NCBiotech News

  • NCBiotech President and CEO Doug Edgeton did some prognosticating at a luncheon briefing preceding Tuesday’s opening of the two-day 2016 CED Life Science Conference at the Raleigh Convention Center, presented each year by CED in partnership with NCBiotech and NCBio.
  • Leaders of four NCSU life science spinouts shared their growing pains and triumphs with more than 100 people gathered in a ballroom at the Raleigh Convention Center during a pre-conference panel discussion to kick off the 2016 CED Life Science Conference.
  • Innovate Biopharmaceuticals of Raleigh has completed an agreement to license all of Alba Therapeutics’ assets relating to larazotide acetate, a drug candidate progressing toward phase three clinical trials for the treatment of celiac disease.
  • West Pharmaceutical Services, a global designer and manufacturer of pharmaceutical packaging and delivery systems, will invest $19 million to upgrade its production plant in Kinston.
  • Precision BioSciences, a 2006 Duke University spin-out with a unique method to target and alter DNA, has signed a development deal with Baxalta that could bring the Research Triangle Park biotechnology company up to $1.6 billion.
  • Durham-based Bioventus has signed a multi-year agreement with IBSA (Institut Biochimique SA), a Swiss pharmaceutical company, to secure the exclusive U.S. distribution rights for GELSYN-3, a three-injection, hyaluronic acid product for pain relief from osteoarthritis of the knee.
  • North Carolina voters will not only cast ballots for their favorite presidential candidate in the March 15 primary election. They will also decide a $2 billion state bond referendum that has long-term implications for North Carolina’s life science community.
  • Severe weather is causing problems across North Carolina. For Wednesday, Feb. 24, 2016, NCBiotech reports the following changes to normal office hours:
  • Chapel Hill gene therapy startup Bamboo Therapeutics raised a whopping $49.5 million from six investors, to advance its battle against childhood neurological diseases.
  • NCBiotech will inaugurate a quarterly Life Sciences Forum series on Monday, February 29, with a panel discussion designed to reinforce how venture philanthropy can, and does, play an increasingly significant role in life science product development.
  • Bioscience briefs with names making news
  • SoBran BioScience, a 500-employee contract research organization based in Fairfax, Va., will open a new animal research facility this summer in Greensboro.
  • Chapel Hill bioscience company BioKier has received a $1.6 million grant from the National Institutes of Health to advance development of the company’s unique approach to treating Type 2 diabetes, also known as noninsulin-dependent diabetes.
  • It wasn’t always Syngenta. And if regulators approve this week’s $43 billion buyout offer from Chinese state-owned China National Chemical Corp., aka ChemChina, it’s likely to remain in North Carolina, but it won’t be Syngenta much longer.
  • Cempra, a Chapel Hill company that’s developing antibiotics to treat bacterial infections, has signed a deal with a Massachusetts firm to streamline the production process for Cempra’s lead drug candidate, solithromycin.
  • The North Carolina Biotechnology Center awarded more than $1.63 million in 18 loans and grants to propel the life science sector statewide during the quarter ended December 31, 2015.
  • The two-day “basics of biotechnology” course offered around the country by the BioTech Primer science education company is coming to Durham March 17 and 18.
  • Zoion Pharma of Durham has formed a collaboration with the French veterinary company Ceva Santé Animale to develop a treatment for eye diseases in companion animals.
  • Research Triangle Park startup CertiRx is teaming with a Croatian company, IN2trace Ltd., to combine its TraxSecur authentication technology with IN2trace’s CureCloud “serialization” technology into one software package, called TraxSecur Serialized Security.
  • With potential for icy road conditions around the Triangle on Tuesday morning, the Biotech Center will open at 10 a.m. Tuesday, January 26, 2016. Check back for updates.  


Subscribe to News & Events